• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

EncounterCare Solutions, Inc. Announces Installation of CyberMedx Medical Systems' WaveLynx Alarm Management System to Shands Hospital at the University of Florida

Posted on: Thursday, 24 August 2006, 15:00 CDT

Ronald W. Mills Sr., CEO of EncounterCare Solutions Inc. (Pink Sheets: ECSL), announced today that CyberMedx Medical Systems, an EncounterCare Solutions wholly owned subsidiary, has completed the WaveLynx installation into Shands hospital at the University of Florida.

Ronald R. Barnett, President/CEO of CyberMedx, stated, "We are thrilled about the WaveLynx 24 bed ventilator alarm system installation at Shands Healthcare, one of the southeast's premier health systems. It substantiates our mission at CyberMedx to significantly improve quality patient care and substantially reduce health care costs by maximizing information and communication management technology." Mr. Barnett added, "The WaveLynx wireless alarm management system is an extremely flexible platform. WaveLynx provides alarm notification for dry contact based alarms in several formats, i.e. enunciator, email, SMS, and pop up windows on configured computers on the network. WaveLynx also provides alarm documentation and video capabilities."

CyberMedx Medical Systems provides patient data management, communication, and information systems to the hospital and home care industries. CyberMedx has developed the InteleNett(TM) family of patient data management products for hospitals and the STATus(TM) family of device data management products for home care. These systems increase productivity, reduce cost, improve efficiency, and extend the operational life expectancy of existing patient monitoring and therapy delivery services.

Additionally, Mr. Mills stated that this installation is the first of a series of new product sales which focus on the hospital and alternate care markets. EncounterCare Solutions is currently negotiating with a U.S. Fortune 100 company for worldwide distribution and sales of this new product line. The Company is also in negotiation with one of Europe's largest medical distributors for European and Asian market coverage. This is an integral part of our marketing strategy.

Certain statements and information included in this press release constitute "forward looking statements" within the meaning of the Federal Private Securities Litigation Act of 1995. When used in this press release, the words or phrases "will likely result,""expected to,""will continue,""anticipated,""estimate,""projected,""intends," or similar expressions are intended to identify "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements are subject to certain risks, known and unknown, and uncertainties, including but not limited to, economic conditions, dependence on management, dilution to shareholders, lack of capital changes in laws or regulations, the affects of rapid growth upon the Company and the ability of management to effectively respond to the growth, demand for products and services of the Company, newly developing technologies, its ability to compete, conflicts of interest related to party transactions, regulatory matters, protection of technology, lack of industry standards, the effects of competition, and the ability of the Company to obtain additional financing. Such factors could materially adversely affect the Company's financial performance and could cause the Company's actual results for future periods to differ materially from any opinions or statements expressed within this press release.

Source: Business Wire

More News in this Category